Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease

NCT04855305 is registered in ClinicalTrials.gov with Bastiaan Driehuys as lead sponsor.

NCT NCT04855305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04855305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Lead sponsor
Bastiaan Driehuys
Phase
Phase 2
Overall status
Completed
Start date
November 12, 2021
Completion date
June 11, 2025
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung diseases